Potent interaction of flavopiridol with MRP1

J.H. Hooijberg; H.J. Broxterman; G.L. Scheffer; C. Vrasdonk; M. Heijn; M.C. de Jong; R.J. Scheper; J. Lankelma; H.M. Pinedo

doi:10.1038/sj.bjc.6690687

Potent interaction of flavopiridol with MRP1

J.H. Hooijberg
, H.J. Broxterman
, G.L. Scheffer
, C. Vrasdonk
, M. Heijn
, M.C. de Jong
, R.J. Scheper
, J. Lankelma
, H.M. Pinedo

Research output: Contribution to Journal › Article › Academic

162 Downloads (Pure)

Abstract

The multidrug resistance protein 1 (MRP1) is an ATP-dependent transport protein for organic anions, as well as neutral or positively charged anticancer agents. In this study we show that flavopiridol, a synthetic flavonoid currently studied in phase 1 trials for its anti-prolifetative characteristics, interacts with MRP1 in a potent way. Flavopiridol, as well as other (iso)flavonoids stimulate the ATPase activity of MRP1 in a dose-dependent way at low micromolar concentrations. A new specific monoclonal antibody against MRP1 (MIB6) inhibits the (iso)flavonoid-induced ATPase activity of plasma membrane vesicles prepared from the MRP1 overexpressing cell line GLC

Original language	English
Pages (from-to)	269-276
Journal	British Journal of Cancer
Volume	81
DOIs	https://doi.org/10.1038/sj.bjc.6690687
Publication status	Published - 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/sj.bjc.6690687

PMC2362861Final published version, 132 KB

Persistent URL (handle)

Persistent link

Cite this

@article{adc9dd108afb4d50aa29bc7fb481357b,

title = "Potent interaction of flavopiridol with MRP1",

abstract = "The multidrug resistance protein 1 (MRP1) is an ATP-dependent transport protein for organic anions, as well as neutral or positively charged anticancer agents. In this study we show that flavopiridol, a synthetic flavonoid currently studied in phase 1 trials for its anti-prolifetative characteristics, interacts with MRP1 in a potent way. Flavopiridol, as well as other (iso)flavonoids stimulate the ATPase activity of MRP1 in a dose-dependent way at low micromolar concentrations. A new specific monoclonal antibody against MRP1 (MIB6) inhibits the (iso)flavonoid-induced ATPase activity of plasma membrane vesicles prepared from the MRP1 overexpressing cell line GLC",

author = "J.H. Hooijberg and H.J. Broxterman and G.L. Scheffer and C. Vrasdonk and M. Heijn and \{de Jong\}, M.C. and R.J. Scheper and J. Lankelma and H.M. Pinedo",

year = "1999",

doi = "10.1038/sj.bjc.6690687",

language = "English",

volume = "81",

pages = "269--276",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Potent interaction of flavopiridol with MRP1

AU - Hooijberg, J.H.

AU - Broxterman, H.J.

AU - Scheffer, G.L.

AU - Vrasdonk, C.

AU - Heijn, M.

AU - de Jong, M.C.

AU - Scheper, R.J.

AU - Lankelma, J.

AU - Pinedo, H.M.

PY - 1999

Y1 - 1999

N2 - The multidrug resistance protein 1 (MRP1) is an ATP-dependent transport protein for organic anions, as well as neutral or positively charged anticancer agents. In this study we show that flavopiridol, a synthetic flavonoid currently studied in phase 1 trials for its anti-prolifetative characteristics, interacts with MRP1 in a potent way. Flavopiridol, as well as other (iso)flavonoids stimulate the ATPase activity of MRP1 in a dose-dependent way at low micromolar concentrations. A new specific monoclonal antibody against MRP1 (MIB6) inhibits the (iso)flavonoid-induced ATPase activity of plasma membrane vesicles prepared from the MRP1 overexpressing cell line GLC

AB - The multidrug resistance protein 1 (MRP1) is an ATP-dependent transport protein for organic anions, as well as neutral or positively charged anticancer agents. In this study we show that flavopiridol, a synthetic flavonoid currently studied in phase 1 trials for its anti-prolifetative characteristics, interacts with MRP1 in a potent way. Flavopiridol, as well as other (iso)flavonoids stimulate the ATPase activity of MRP1 in a dose-dependent way at low micromolar concentrations. A new specific monoclonal antibody against MRP1 (MIB6) inhibits the (iso)flavonoid-induced ATPase activity of plasma membrane vesicles prepared from the MRP1 overexpressing cell line GLC

U2 - 10.1038/sj.bjc.6690687

DO - 10.1038/sj.bjc.6690687

M3 - Article

SN - 0007-0920

VL - 81

SP - 269

EP - 276

JO - British Journal of Cancer

JF - British Journal of Cancer

ER -

Potent interaction of flavopiridol with MRP1

Abstract

UN SDGs

Access to Document

Persistent URL (handle)

Fingerprint

Cite this